Entegris (ENTG) 10-Q 2 Aug 22 2022 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	6 Months Ended
	Jul. 02, 2022	Jul. 29, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 02, 2022
Document Transition Report	false
Entity File Number	001-32598
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	129 Concord Road,
Entity Address, City or Town	Billerica,
Entity Address, State or Province	MA
Entity Tax Identification Number	41-1941551
Entity Address, Postal Zip Code	01821
City Area Code	978
Local Phone Number	436-6500
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of 12(b) Security	Common stock, $0.01 par value per share
Trading Symbol	ENTG
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		148,964,227
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Entity Registrant Name	ENTEGRIS INC
Entity Central Index Key	0001101302
Current Fiscal Year End Date	--12-31

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 02, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 252,950	$ 402,565
Restricted cash	2,490,281	0
Trade accounts and notes receivable, net of allowance for credit losses of $3,161 and $2,349	381,251	347,413
Inventories, net	583,766	475,213
Deferred tax charges and refundable income taxes	38,907	35,312
Other current assets	129,003	52,867
Total current assets	3,876,158	1,313,370
Property, plant and equipment, net of accumulated depreciation of $696,495 and $653,104	779,631	654,098
Other assets:
Right-of-use assets	68,389	66,563
Goodwill	789,540	793,702
Intangible assets, net of accumulated amortization of $519,911 and $494,601	308,871	335,113
Deferred tax assets and other noncurrent tax assets	26,549	17,671
Other	12,033	11,379
Total assets	5,861,171	3,191,896
Current liabilities:
Accounts payable	146,441	130,734
Accrued payroll and related benefits	69,623	108,818
Accrued interest payable	33,743	6,073
Other accrued liabilities	94,805	84,240
Income taxes payable	48,523	49,136
Total current liabilities	393,135	379,001
Long-term debt, excluding current maturities, net of unamortized discount and debt issuance costs of $39,199 and $7,973	3,408,801	937,027
Pension benefit obligations and other liabilities	35,631	37,816
Deferred tax liabilities and other noncurrent tax liabilities	49,997	64,170
Long-term lease liability	60,893	60,101
Commitments and contingent liabilities	0	0
Equity:
Preferred stock, par value $.01; 5,000,000 shares authorized; none issued and outstanding as of July 2, 2022 and December 31, 2021	0	0
Common stock, par value $.01; 400,000,000 shares authorized; issued and outstanding shares as of July 2, 2022: 136,172,896 and 135,970,496, respectively; issued and outstanding shares as of December 31, 2021: 135,719,366 and 135,516,966, respectively	1,362	1,357
Treasury stock, at cost: 202,400 shares held as of July 2, 2022 and December 31, 2021	(7,112)	(7,112)
Additional paid-in capital	891,967	879,845
Retained earnings	1,077,651	879,776
Accumulated other comprehensive loss	(51,154)	(40,085)
Total equity	1,912,714	1,713,781
Total liabilities and equity	$ 5,861,171	$ 3,191,896

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jul. 02, 2022	Dec. 31, 2021
Trade accounts and notes receivable, allowance for doubtful accounts	$ 3,161	$ 2,349
Property, plant and equipment, accumulated depreciation	696,495	653,104
Intangible assets, Accumulated amortization	519,911	494,601
Unamortized discount and debt issuance costs	$ 39,199	$ 7,973
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	400,000,000	400,000,000
Common stock, shares issued	136,172,896	135,719,366
Common stock, shares outstanding	135,970,496	135,516,966
Treasury stock, shares outstanding	202,400	202,400

Condensed Consolidated Statemen

Condensed Consolidated Statements Of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 02, 2022	Jul. 03, 2021	Jul. 02, 2022	Jul. 03, 2021
Net Sales	$ 692,489	$ 571,352	$ 1,342,135	$ 1,084,196
Cost of sales	382,092	305,968	721,918	583,826
Gross profit	310,397	265,384	620,217	500,370
Selling, general and administrative expenses	90,685	72,621	177,793	144,010
Engineering, research and development expenses	49,248	41,972	95,963	79,720
Amortization of intangible assets	12,494	11,902	25,145	23,773
Operating income	157,970	138,889	321,316	252,867
Interest expense	32,001	10,697	44,877	22,349
Interest income	(658)	(54)	(670)	(125)
Other expense, net	9,619	23,560	14,521	27,890
Income before income tax expense	117,008	104,686	262,588	202,753
Income tax expense	17,517	15,916	37,392	29,307
Net income	$ 99,491	$ 88,770	$ 225,196	$ 173,446
Basic earnings per common share	$ 0.73	$ 0.66	$ 1.66	$ 1.28
Diluted earnings per common share	$ 0.73	$ 0.65	$ 1.65	$ 1.27
Weighted shares outstanding:
Basic	135,895	135,498	135,783	135,283
Diluted	136,454	136,533	136,503	136,518

Condensed Consolidated Statem_2

Condensed Consolidated Statements Of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 02, 2022	Jul. 03, 2021	Jul. 02, 2022	Jul. 03, 2021
Net income	$ 99,491	$ 88,770	$ 225,196	$ 173,446
Other comprehensive (loss) income, net of tax
Foreign currency translation adjustments	(9,014)	1,457	(11,142)	(2,259)
Pension liability adjustments	0	0	73	39
Other comprehensive (loss) income	(9,014)	1,457	(11,069)	(2,220)
Comprehensive income	$ 90,477	$ 90,227	$ 214,127	$ 171,226

Condensed Consolidated Statem_3

Condensed Consolidated Statements Of Equity Condensed Consolidatd Statements of Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Treasury Stock, Common	Additional Paid-in Capital	Retained Earnings	Foreign currency translation adjustments	Defined benefit pension adjustments
Balance (in shares) at Dec. 31, 2020		135,149	202
Balance at Dec. 31, 2020	$ 1,379,494	$ 1,351	$ (7,112)	$ 844,850	$ 577,833	$ (36,588)	$ (840)
Shares issued under stock plans (in shares)		392
Shares issued under stock plans	(13,466)	$ 4	0	(13,470)	0	0	0
Share-based compensation expense	7,138	$ 0	0	7,138	0	0	0
Repurchase and retirements of common stock (in shares)		(145)
Repurchase and retirements of common stock	(15,000)	$ (1)	0	(904)	(14,095)	0	0
Dividends declared	(10,832)	0	0	8	(10,840)	0	0
Pension liability adjustments	39	0	0	0	0	0	39
Foreign currency translation adjustments	(3,716)	0	0	0	0	(3,716)	0
Net income	84,676	$ 0	$ 0	0	84,676	0	0
Balance (in shares) at Apr. 03, 2021		135,396	202
Balance at Apr. 03, 2021	1,428,333	$ 1,354	$ (7,112)	837,622	637,574	(40,304)	(801)
Balance (in shares) at Dec. 31, 2020		135,149	202
Balance at Dec. 31, 2020	1,379,494	$ 1,351	$ (7,112)	844,850	577,833	(36,588)	(840)
Pension liability adjustments	39
Foreign currency translation adjustments	(2,259)
Net income	173,446
Balance (in shares) at Jul. 03, 2021		135,825	202
Balance at Jul. 03, 2021	1,515,331	$ 1,358	$ (7,112)	859,520	701,213	(38,847)	(801)
Balance (in shares) at Apr. 03, 2021		135,396	202
Balance at Apr. 03, 2021	1,428,333	$ 1,354	$ (7,112)	837,622	637,574	(40,304)	(801)
Shares issued under stock plans (in shares)		559
Shares issued under stock plans	15,190	$ 5	0	15,185	0	0	0
Share-based compensation expense	7,519	$ 0	0	7,519	0	0	0
Repurchase and retirements of common stock (in shares)		(130)
Repurchase and retirements of common stock	(15,000)	$ (1)	0	(813)	(14,186)	0	0
Dividends declared	(10,938)	0	0	7	(10,945)	0	0
Pension liability adjustments	0
Foreign currency translation adjustments	1,457	0	0	0	0	1,457	0
Net income	88,770	$ 0	$ 0	0	88,770	0	0
Balance (in shares) at Jul. 03, 2021		135,825	202
Balance at Jul. 03, 2021	1,515,331	$ 1,358	$ (7,112)	859,520	701,213	(38,847)	(801)
Balance (in shares) at Dec. 31, 2021		135,719	202
Balance at Dec. 31, 2021	1,713,781	$ 1,357	$ (7,112)	879,845	879,776	(38,863)	(1,222)
Shares issued under stock plans (in shares)		366
Shares issued under stock plans	(12,738)	$ 4	0	(12,742)	0	0	0
Share-based compensation expense	9,285	0	0	9,285	0	0	0
Dividends declared	(13,660)	0	0	0	(13,660)	0	0
Pension liability adjustments	73	0	0	0	0	0	73
Foreign currency translation adjustments	(2,128)	0	0	0	0	(2,128)	0
Net income	125,705	$ 0	$ 0	0	125,705	0	0
Balance (in shares) at Apr. 02, 2022		136,085	202
Balance at Apr. 02, 2022	1,820,318	$ 1,361	$ (7,112)	876,388	991,821	(40,991)	(1,149)
Balance (in shares) at Dec. 31, 2021		135,719	202
Balance at Dec. 31, 2021	1,713,781	$ 1,357	$ (7,112)	879,845	879,776	(38,863)	(1,222)
Pension liability adjustments	73
Foreign currency translation adjustments	(11,142)
Net income	225,196
Balance (in shares) at Jul. 02, 2022		136,173	202
Balance at Jul. 02, 2022	1,912,714	$ 1,362	$ (7,112)	891,967	1,077,651	(50,005)	(1,149)
Balance (in shares) at Apr. 02, 2022		136,085	202
Balance at Apr. 02, 2022	1,820,318	$ 1,361	$ (7,112)	876,388	991,821	(40,991)	(1,149)
Shares issued under stock plans (in shares)		88
Shares issued under stock plans	5,398	$ 1	0	5,397	0	0	0
Share-based compensation expense	10,182	0	0	10,182	0	0	0
Dividends declared	(13,661)	0	0	0	(13,661)	0	0
Pension liability adjustments	0
Foreign currency translation adjustments	(9,014)	0	0	0	0	(9,014)	0
Net income	99,491	$ 0	$ 0	0	99,491	0	0
Balance (in shares) at Jul. 02, 2022		136,173	202
Balance at Jul. 02, 2022	$ 1,912,714	$ 1,362	$ (7,112)	$ 891,967	$ 1,077,651	$ (50,005)	$ (1,149)

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Equity (Parenthetical) - $ / shares	3 Months Ended
	Jul. 02, 2022	Apr. 02, 2022	Jul. 03, 2021	Apr. 03, 2021
Statement of Stockholders' Equity [Abstract]
Common Stock, Dividends, Per Share, Declared	$ 0.10	$ 0.10	$ 0.08	$ 0.08

Condensed Consolidated Statem_5

Condensed Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 02, 2022	Jul. 03, 2021
Operating activities:
Net income	$ 225,196	$ 173,446
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	48,286	44,669
Amortization	25,145	23,773
Share-based compensation expense	19,467	14,657
Provision for deferred income taxes	(23,472)	(4,920)
Loss on extinguishment of debt and modification	0	23,338
Charge for excess and obsolete inventory	13,916	5,873
Other	18,243	(1,156)
Changes in operating assets and liabilities:
Trade accounts and notes receivable	(57,309)	(48,231)
Inventories	(124,941)	(69,723)
Accounts payable and accrued liabilities	27,145	(15,347)
Other current assets	(2,592)	10,882
Income taxes payable and refundable income taxes	(3,548)	(26,442)
Other	9,162	4,151
Net cash provided by operating activities	174,698	134,970
Investing activities:
Acquisition of property, plant and equipment	(192,097)	(85,101)
Acquisition of businesses, net of cash acquired	0	(2,250)
Other	1,123	90
Net cash used in investing activities	(190,974)	(87,261)
Financing activities:
Proceeds from revolving credit facility	201,000	51,000
Payments of revolving credit facility	(193,000)	(51,000)
Proceeds from long-term debt	2,405,314	400,000
Payments of long-term debt	0	(550,000)
Payments for debt extinguishment costs	0	(19,080)
Payments for debt issuance costs	(10,579)	(4,691)
Payments for dividends	(27,484)	(21,797)
Issuance of common stock	8,977	16,817
Repurchase and retirement of common stock	0	(30,000)
Taxes paid related to net share settlement of equity awards	(16,317)	(15,093)
Other	(587)	(110)
Net cash provided by (used in) financing activities	2,367,324	(223,954)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	(10,382)	(3,615)
Increase (decrease) in cash, cash equivalents and restricted cash	2,340,666	(179,860)
Cash, cash equivalents and restricted cash at beginning of period	402,565	580,893
Cash, cash equivalents and restricted cash at end of period	2,743,231	401,033
Supplemental Cash Flow Information
Deferred acquisition payments	0	250
Original issue discount credit due from lender	65,389	0
Equipment purchases in accounts payable	23,394	9,165
Increase in dividends payable	163	27
Schedule of interest and taxes paid
Interest paid less capitalized interest	15,699	28,778
Income taxes paid, net of refunds received	$ 62,168	$ 58,297

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jul. 02, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Nature of Operations Entegris, Inc. (“Entegris”, “the Company”, “us”, “we”, or “our”) is a leading supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. Intercompany profits, transactions and balances have been eliminated in consolidation. Use of Estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, particularly receivables, inventories, property, plant and equipment, right-of-use assets, goodwill, intangibles, accrued expenses, short-term and long-term lease liability, income taxes and related accounts, and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Basis of Presentation The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States and contain all adjustments considered necessary, and are of a normal recurring nature, to present fairly the financial position as of July 2, 2022 and December 31, 2021, and the results of operations and comprehensive income for the three and six months ended July 2, 2022 and July 3, 2021, the equity statements as of and for the three and six months ended July 2, 2022 and July 3, 2021, and cash flows for the six months ended July 2, 2022 and July 3, 2021. The condensed consolidated financial statements and accompanying notes are presented as permitted by Form 10-Q and do not contain certain information included in the Company’s annual consolidated financial statements and notes. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with Management’s Discussion and Analysis and consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The results of operations for the three and six months ended July 2, 2022 are not necessarily indicative of the results to be expected for the full year. Fair Value of Financial Instruments The carrying value of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued payroll and related benefits, and other accrued liabilities approximates fair value due to the short maturity of those items. The fair value of long-term debt, including current maturities, was $3,141.8 million at July 2, 2022, compared to the carrying amount of long-term debt, including current maturities, of $3,408.8 million at July 2, 2022. Recently Adopted Accounting Pronouncements The Company currently has no material recently adopted accounting pronouncements.

Revenues Revenues

Revenues Revenues	6 Months Ended
	Jul. 02, 2022
Revenues [Abstract]
Revenue from Contract with Customer	REVENUES The following table provides information about current contract liabilities from contracts with customers. The contract liabilities are included in other accrued liabilities balance in the condensed consolidated balance sheet. (In thousands) July 2, 2022 July 3, 2021 Balance at beginning of period $ 23,050 $ 13,852 Revenue recognized that was included in the contract liability balance at the beginning of the period (15,585) (12,306) Increases due to cash received, excluding amounts recognized as revenue during the period 25,770 17,060 Balance at end of period $ 33,235 $ 18,606

Acquisition

Acquisition	6 Months Ended
	Jul. 03, 2021
Business Combinations [Abstract]
Business Combination Disclosure	ACQUISITIONS CMC Materials On July 6, 2022 (the “Closing Date”), the Company completed its acquisition of CMC Materials, Inc. (“CMC Materials” or “CMC”). The Company acquired all of the issued and outstanding common shares of CMC Materials for $133.00 in cash and 0.4506 shares of the Company’s common stock per share, (the “Merger Consideration”), representing a total purchase price (inclusive of debt retired and cash assumed) at close of approximately $5.7 billion (based on the Company’s closing price on June 30, 2022), including $3.8 billion in cash paid to CMC Materials’ stockholders, the issuance of 12.9 million shares of the Company’s common stock (excluding unvested CMC stock options and unvested CMC restricted stock units, restricted shares and performance share unit equity awards assumed), approximately $0.9 billion of debt retired and approximately $200 million of acquired cash. The Company financed the cash portion of the purchase price through debt financing. Certain information necessary to complete the preliminary purchase price allocation related to the acquisition was not yet available as of the date of this Quarterly Report. Precision Microchemicals On November 30, 2021, the Company completed its acquisition of the Precision Microchemicals business from BASF SE. As of the date of this Quarterly Report, the Precision Microchemicals business reports into the Specialty Chemicals and Engineered Materials segment of the Company. The acquisition was accounted for under the acquisition method of accounting, and the Precision Microchemicals business results of operations are included in the Company’s consolidated financial statements as of and since November 30, 2021. The acquisition does not constitute a material business combination. The purchase price for the Precision Microchemical business included cash consideration of $89.7 million (net of cash acquired), which was funded from the Company’s existing cash on hand. The purchase price of the Precision Microchemical business exceeded the net of the acquisition-date amounts of the identifiable assets acquired and the liabilities assumed by $42.8 million. Cash flows used to determine the purchase price included strategic and synergistic benefits (investment value) specific to the Company, which resulted in a purchase price in excess of the fair value of identifiable net assets. This additional investment value resulted in goodwill, which is expected to be deductible for income tax purposes. The fair value of acquired identifiable intangible assets was determined using Level 3 inputs for the “income approach” on an individual asset basis. The key assumptions used in the calculation of the discounted cash flows include future revenue growth rates, future gross margin, future selling, general and administrative expense, royalty rates, and discount rates. The valuations and the underlying assumptions have been deemed reasonable by the Company’s management. There are inherent uncertainties and management judgment required in these determinations. During the quarter ended April 2, 2022, the Company finalized its fair value determination of the assets acquired and the liabilities assumed. The following table summarizes the final allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed at the date of the acquisition: (In thousands): November 30, 2021 As of April 2, 2022 Inventories, net $ 967 $ 967 Other current assets 19 19 Identifiable intangible assets 44,910 44,910 Right-of-use assets 1,912 1,912 Property, plant and equipment 1,002 1,002 Other noncurrent assets 18 18 Accounts payable and accrued liabilities (43) (30) Short-term lease liability (170) (170) Long-term lease liability (1,742) (1,742) Net assets acquired 46,873 46,886 Goodwill 42,819 42,824 Total purchase price, net of cash acquired $ 89,692 $ 89,710 The Company recognized the following finite-lived intangible assets as part of the acquisition of the Precision Microchemicals business: (In thousands) Amount Weighted Developed technology $ 9,600 9.0 Trademarks and trade names 3,400 15.0 Customer relationships 31,800 15.5 Other 110 $ 44,910 14.1

Cash, Cash Equivalents and Rest

Cash, Cash Equivalents and Restricted Cash	6 Months Ended
	Jul. 02, 2022
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]
Restricted Assets Disclosure	The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheet that sum to the total of the same amounts shown in the condensed consolidated statement of cash flows. (In thousands) July 2, 2022 December 31, 2021 Cash and cash equivalents $ 252,950 $ 402,565 Restricted cash 2,490,281 — Total cash, cash equivalents and restricted cash $ 2,743,231 $ 402,565 The restricted cash represents cash held in an escrow account designated to fund the CMC Materials acquisition, further described in footnote 3. The Company deposited the net proceeds from the offerings of the Senior Unsecured Notes due 2030 and Senior Secured Notes due 2029, further described in footnote 7, along with certain additional funds, into an escrow account designated for the purchase. The restricted cash is not available to the Company for general corporate purposes.

Inventories

Inventories	6 Months Ended
	Jul. 02, 2022
Inventory Disclosure [Abstract]
Inventories	INVENTORIES Inventories consist of the following: (In thousands) July 2, 2022 December 31, 2021 Raw materials $ 258,188 $ 191,986 Work-in-process 49,866 40,257 Finished goods 275,712 242,970 Total inventories, net $ 583,766 $ 475,213

Goodwill and Intangible Assets

Goodwill and Intangible Assets	6 Months Ended
	Jul. 02, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	GOODWILL AND INTANGIBLE ASSETS Goodwill activity for each of the Company’s reportable segments that carry goodwill, Specialty Chemicals and Engineered Materials (“SCEM”), Microcontamination Control (“MC”) and Advanced Materials Handling (“AMH”), for each period was as follows: (In thousands) Specialty Chemicals and Engineered Materials Microcontamination Control Advanced Materials Handling Total December 31, 2021 $ 470,875 $ 248,725 $ 74,102 $ 793,702 Purchase accounting adjustments 5 — — 5 Foreign currency translation (64) (4,103) — (4,167) July 2, 2022 $ 470,816 $ 244,622 $ 74,102 $ 789,540 Identifiable intangible assets at July 2, 2022 and December 31, 2021 consist of the following: July 2, 2022 (In thousands) Gross carrying Accumulated Net carrying Developed technology $ 293,829 $ 238,523 $ 55,306 Trademarks and trade names 33,442 21,290 12,152 Customer relationships 481,224 245,190 236,034 Other 20,287 14,908 5,379 $ 828,782 $ 519,911 $ 308,871 December 31, 2021 (In thousands) Gross carrying Accumulated Net carrying Developed technology $ 293,982 $ 232,722 $ 61,260 Trademarks and trade names 33,553 20,340 13,213 Customer relationships 481,674 227,350 254,324 Other 20,505 14,189 6,316 $ 829,714 $ 494,601 $ 335,113 Future amortization expense during the remainder of 2022, each of the succeeding four years and thereafter relating to intangible assets currently recorded in the Company’s condensed consolidated balance sheets is estimated to be the following at July 2, 2022: (In thousands) Remaining 2022 2023 2024 2025 2026 Thereafter Total Future amortization expense $ 25,553 50,280 37,490 31,129 28,901 135,518 $ 308,871

Debt

Debt	6 Months Ended
	Jul. 02, 2022
Debt Disclosure [Abstract]
Debt Disclosure	DEBT Long-term debt as of July 2, 2022 and December 31, 2021 consists of the following: (In thousands) July 2, 2022 December 31, 2021 Senior unsecured notes due 2030 $ 895,000 $ — Senior secured notes due 2029 1,600,000 — Senior unsecured notes due 2029 400,000 400,000 Senior unsecured notes due 2028 400,000 400,000 Senior secured term loan facility due 2025 1 145,000 145,000 Revolving facility due 2026 8,000 — 3,448,000 945,000 Unamortized discount and debt issuance costs 39,199 7,973 Total long-term debt $ 3,408,801 $ 937,027 Annual maturities of long-term debt, excluding unamortized discount and issuance costs, due as of July 2, 2022 are as follows: (In thousands) 2022 2023 2024 2025 1 2026 Thereafter Total Contractual debt obligation maturities* $ — — — 145,000 8,000 3,295,000 $ 3,448,000 *Subject to Excess Cash Flow payments to the lenders. 1 The senior secured term loan facility due 2025 was repaid in full with the completion of the CMC Materials. acquisition on the Closing Date. CMC Materials Acquisition Financing Subsequent to the closing of the quarter, on the Closing Date, the Company completed the acquisition CMC Materials pursuant to the terms of the previously announced Agreement and Plan of Merger, dated as of December 14, 2021 (the “Merger Agreement”), by and among the Company, CMC Materials and Yosemite Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of the Company (“Merger Sub”). Pursuant to the Merger Agreement, Merger Sub merged with and into CMC (the “Merger”), with CMC Materials surviving the Merger and becoming a wholly-owned subsidiary of the Company. On the Closing Date, the Company and certain of its subsidiaries entered into an Amendment and Restatement Agreement (the “Amendment”), which amended and restated the Credit and Guaranty Agreement, dated as of November 6, 2018 (as previously amended, restated, amended and restated, supplemented, modified and otherwise in effect prior to the effectiveness of the Amendment, the “Existing Credit Agreement” and, the Existing Credit Agreement as amended by the Amendment, the “Amended Credit Agreement”), by and among the Company, as borrower, certain subsidiaries of the Company party thereto, as guarantors, the lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent and collateral agent. The Amended Credit Agreement provides for senior secured credit facilities in an aggregate principal amount equal to $3.1 billion, consisting of (a) a senior secured term loan credit facility in an aggregate principal amount equal to $2.495 billion (the “Initial Term Loan Facility”) and (b) a senior secured revolving credit facility in an aggregate amount equal to $575.0 million (the “Revolving Facility” and, together with the Initial Term Loan Facility, the “Credit Facilities”). The Revolving Facility contains sublimits for swingline loans and the issuances of letters of credit. The commitments under the Revolving Facility expire on July 6, 2027, and any loans then outstanding will be payable in full at that time. All outstanding loans under Initial Term Loan Facility are due and payable on July 6, 2029. The obligations under the Credit Facilities are guaranteed by certain of the Company’s wholly-owned domestic restricted subsidiaries (collectively, the “Subsidiary Guarantors”), subject to customary exceptions and limitations. The obligations under the Credit Facility are secured by a first-priority lien on substantially all of the assets of the Company and the Subsidiary Guarantors, subject to customary exceptions and limitations, on a pari passu basis with the obligations under the Secured Notes, pursuant to customary intercreditor arrangements. Borrowings under the Initial Term Loan Facility bear interest at a rate per annum equal to, at the Company’s option, either (i) Term Secured Overnight Financing Rate (“SOFR”) plus an applicable margin of 3.00% or (ii) a base rate plus an applicable margin of 2.00%. Borrowings under the Revolving Facility bear interest at a rate per annum equal to, at the Company’s option, either (i) Term SOFR, in the case of US dollar denominated borrowings, or the applicable benchmark rate as further described in the Amended Credit Agreement, in the case of any other currency, in each case, plus an applicable margin of 1.75% or (ii) a base rate, plus an applicable margin of 0.75%. The applicable margin set forth in the Amended Credit Agreement steps-down depending on the First Lien Net Leverage Ratio. The Amended Credit Agreement also contains customary unused commitment fees, letter of credit fees and agency fees. The Amended Credit Agreement contains customary representations, warranties and affirmative covenants. The Amended Credit Agreement also includes negative covenants that limit, among other things, incurring additional indebtedness, transactions with affiliates, additional liens, sales of assets, dividends, investments and advances, prepayments of debt and mergers and acquisitions, in each case, subject to certain exceptions, qualifications and baskets. The Amended Credit Agreement also includes a “springing” financial covenant that would require the Company to maintain a First Lien Net Leverage Ratio of 5.20:1.00 or less as of the end of any period of four fiscal quarters ending after December 31, 2022 if at any time the Company has revolving borrowings, unreimbursed letter of credit drawings and undrawn letters of credit (subject to certain exceptions) outstanding in an amount in excess of 35.0% of the aggregate commitments in respect of the Revolving Facility. The Amended Credit Agreement contains customary events of default for facilities of this type. If an event of default occurs and is continuing, the Company may be required immediately to repay all amounts outstanding under the Amended Credit Agreement. On the Closing Date, the Company and the Subsidiary Guarantors entered into a 364-Day Bridge Credit and Guaranty Agreement (the “Bridge Credit Agreement”), among the Company, as borrower, certain subsidiaries of the Company party thereto, as guarantors, the lenders party thereto and Morgan Stanley Senior Funding, Inc., as administrative agent. The Bridge Credit Agreement provides for a senior unsecured term loan facility in an aggregate principal amount equal to $275.0 million (the “Bridge Credit Facility”). All outstanding loans under the Bridge Credit Facility are due and payable on the date that is 364 days after the Closing Date. Borrowings under the Bridge Credit Facility bear interest at a rate per annum equal to, at the Company’s option, either (i) Term SOFR plus an applicable margin of 4.55% or (ii) a base rate plus an applicable margin of 3.55%. In addition to paying interest on the outstanding principal under the Bridge Credit Facility, the Company will pay to each lender under the Bridge Credit Agreement duration fees equal to 0.25% of the aggregate outstanding principal amount of such lender’s loans under the Bridge Credit Facility at 90, 180 and 270 days after the Closing Date. The Company’s obligations under the Bridge Credit Facility are guaranteed, on an unsecured basis, by the Subsidiary Guarantors, subject to customary exceptions and limitations. The Bridge Credit Agreement contains customary representations, warranties and affirmative covenants. The Bridge Credit Agreement also includes negative covenants that limit, among other things, additional subsidiary indebtedness, additional liens, sales of assets and mergers and acquisitions, in each case, subject to certain exceptions, qualifications and baskets. The Bridge Credit Agreement contains customary events of default, including, but not limited to, payment defaults, breaches of representations and warranties, covenant defaults, events of bankruptcy and insolvency, and a change of control. If an event of default occurs and is continuing, the Company may be required immediately to repay all amounts outstanding under the Bridge Credit Agreement. The Company began incurring ticking fees associated with the Initial Term Loan Facility on March 2, 2022 through the Closing Date. The ticking fees were paid in cash to the term loan lenders on the Closing Date. For the three and six months ended July 2, 2022, the Company incurred $6.9 million and $11.6 million in ticking fees, respectively, which were recorded to interest expense in the condensed consolidated statement of operations. Senior Secured Notes Due 2029 and Senior Unsecured Notes Due 2030 On April 14, 2022, the Company, via a wholly-owned escrow subsidiary (the “Escrow Issuer”), issued $1.6 billion aggregate principal amount of 4.750% senior secured notes due April 15, 2029 (the “2029 Notes”) pursuant to an indenture dated as of April 14, 2022 (the “2029 Notes Indenture”), by and between the Escrow Issuer and Truist Bank (“Truist”), as trustee and as notes collateral agent. Interest on the 2029 Notes is payable semi-annually in arrears on April 15 and October 15 of each year, commencing on October 15, 2022. The Company incurred debt issuance costs of $6.3 million in connection with the 2029 Notes. These costs are reported in the Company’s condensed consolidated balance sheet as a direct deduction from the face amount of the 2029 Notes, along with $7.6 million of original issue discount costs. On June 30, 2022, the Company, via the Escrow Issuer, issued $895 million aggregate principal amount of 5.950% senior unsecured notes due June 15, 2030 (the “2030 Notes” and together with the 2029 Notes, the “New Notes”) pursuant to an indenture, dated as of June 30, 2022 (the “2030 Notes Indenture” and together with the 2029 Notes Indenture, the “New Notes Indentures”), by and between the Escrow Issuer and Truist. Interest on the 2030 Notes is payable semi-annually in arrears on June 15 and December 15 of each year, commencing on June 15, 2022. The Company incurred debt issuance costs of $1.7 million in connection with the 2030 Notes. These costs are reported in the Company’s condensed consolidated balance sheet as a direct deduction from the face amount of the 2030 Notes along with $16.7 million of net original issue discount costs. On the Closing Date, the Escrow Issuer merged with and into the Company and, in connection therewith, the Company executed a supplemental indenture to each New Notes Indenture and such Company subsidiaries agreed to guarantee the Company’s obligations under the New Notes. Accordingly, each series of New Notes is guaranteed, jointly and severally, fully and unconditionally, on a senior basis, by the Company’s existing and future domestic subsidiaries, other than certain excluded subsidiaries, to the extent that such subsidiaries guarantee indebtedness under the Amended Credit Agreement or existing senior notes. In addition, the 2029 Notes and related guarantees are secured, subject to permitted liens and certain other exceptions, by first priority liens on substantially the same collateral that secures the obligations under the Amended Credit Agreement. The Company may, at its option, redeem, at any time and from time to time prior to June 15, 2025, some or all of the 2029 Notes at 100% of the principal amount thereof plus the applicable “make-whole” premium as set forth in the 2029 Notes Indenture plus accrued and unpaid interest, if any, to, but excluding, the redemption date. On or after June 15, 2025, the Company may redeem some or all of the 2029 Notes at the applicable prices set forth in the 2029 Notes Indenture plus accrued and unpaid interest, if any, to, but excluding, the redemption date. In addition, the Company may redeem up to 40% of the principal amount of the 2029 Notes before June 15, 2025 with the net proceeds from one or more equity offerings at the applicable price set forth in the 2029 Notes Indenture, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. The Company may, at its option, redeem, at any time and from time to time prior to January 15, 2029 (the “Par Call Date”), some or all of the 2029 Notes at 100% of the principal amount thereof plus accrued and unpaid interest, if any, to the redemption date plus the applicable “make-whole premium” described in the 2029 Notes Indenture. On or after the Par Call Date, the 2029 Notes will be redeemable, at the Company’s option, in whole or in part, at a redemption price equal to 100% of the principal amount of the 2029 Notes to be redeemed plus accrued and unpaid interest, if any, to, but excluding, the redemption date. Upon the occurrence of certain change of control events accompanied by certain ratings events, the Company will be required to offer to repurchase all of the outstanding principal amount of each series of New Notes at a purchase price of 101% of the principal amount thereof, plus accrued and unpaid interest, if any, to, but not including, the date of repurchase. Each New Notes Indenture contains covenants that, among other things, limit the Company’s ability and/or the ability of the Company’s subsidiaries to: incur liens; engage in sales-and-leaseback transactions; and consolidate, merge with or convey, transfer or lease all or substantially all of the Company’s and its subsidiaries’ assets to another person and limits the ability of any non-guarantor subsidiary of the Company to incur indebtedness. These covenants are subject to a number of other limitations and exceptions as set forth in the New Notes Indentures. The Company was in compliance with these covenants at July 2, 2022. Each New Notes Indenture provides for customary events of default (subject in certain cases to customary grace and cure periods) which, if certain of them occur, would permit the trustee or the holders of at least 25% in aggregate principal amount of the then-outstanding applicable series of New Notes to declare the principal of, and interest or premium, if any, and any other monetary obligations on, all the then-outstanding series of New Notes to be due and payable immediately.

Earnings Per Common Share

Earnings Per Common Share	6 Months Ended
	Jul. 02, 2022
Earnings Per Share [Abstract]
Earnings Per Common Share	EARNINGS PER COMMON SHARE Basic earnings per common share (“EPS”) is calculated based on the weighted average number of shares of common stock outstanding during the applicable period. Diluted earnings per common share is calculated based on the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the applicable period. The following table presents a reconciliation of the share amounts used in the computation of basic and diluted earnings per common share: Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Basic—weighted common shares outstanding 135,895 135,498 135,783 135,283 Weighted common shares assumed upon exercise of stock options and vesting of restricted common stock 559 1,035 720 1,235 Diluted—weighted common shares and common shares equivalent outstanding 136,454 136,533 136,503 136,518 The Company excluded the following shares underlying stock-based awards from the calculations of diluted EPS because their inclusion would have been anti-dilutive for the three and six months ended July 2, 2022 and July 3, 2021: Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Shares excluded from calculations of diluted EPS 595 167 519 138

Other expense (income), net

Other expense (income), net	6 Months Ended
	Jul. 02, 2022
Other Income and Expenses [Abstract]
Other expense (income), net	OTHER EXPENSE, NET Other expense, net for the three and six months ended July 2, 2022 and July 3, 2021 consists of the following: Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Loss on foreign currency transactions $ 10,046 $ 98 $ 14,623 $ 4,362 Loss on extinguishment of debt and modification — 23,338 — 23,338 Other, net (427) 124 (102) 190 Other expense, net $ 9,619 $ 23,560 $ 14,521 $ 27,890

Segment Reporting

Segment Reporting	6 Months Ended
	Jul. 02, 2022
Segment Reporting [Abstract]
Segment Reporting	SEGMENT REPORTING The Company’s financial segment reporting reflects an organizational alignment intended to leverage the Company’s unique breadth of capabilities to create mission-critical microcontamination control products, specialty chemicals and advanced materials handling solutions that maximize manufacturing yields, reduce manufacturing costs and enable higher device performance for its customers. While these segments have separate products and technical know-how, they share common business systems and processes, technology centers, and strategic and technology roadmaps. The Company leverages its expertise from these three segments to create new and increasingly integrated solutions for its customers. The Company’s business is reported in the following segments: • Specialty Chemicals and Engineered Materials: SCEM provides high-performance and high-purity process chemistries, gases and materials and safe and efficient delivery systems to support semiconductor and other advanced manufacturing processes. • Microcontamination Control: MC offers solutions to filter and purify critical liquid chemistries and gases used in semiconductor manufacturing processes and other high-technology industries. • Advanced Materials Handling: AMH develops solutions to monitor, protect, transport and deliver critical liquid chemistries, wafers, and other substrates for a broad set of applications in the semiconductor, life sciences and other high-technology industries. Summarized financial information for the Company’s reportable segments is shown in the following tables. Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Net sales SCEM $ 207,729 $ 180,366 $ 404,150 $ 346,907 MC 274,133 227,521 540,770 434,620 AMH 224,084 172,502 422,197 321,043 Inter-segment elimination (13,457) (9,037) (24,982) (18,374) Total net sales $ 692,489 $ 571,352 $ 1,342,135 $ 1,084,196 Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Segment profit SCEM $ 45,718 $ 44,945 $ 94,569 $ 79,501 MC 100,107 78,132 198,725 148,698 AMH 46,926 42,093 93,616 74,188 Total segment profit $ 192,751 $ 165,170 $ 386,910 $ 302,387 The following table reconciles total segment profit to income before income tax expense: Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Total segment profit $ 192,751 $ 165,170 $ 386,910 $ 302,387 Less: Amortization of intangible assets 12,494 11,902 25,145 23,773 Unallocated general and administrative expenses 22,287 14,379 40,449 25,747 Operating income 157,970 138,889 321,316 252,867 Interest expense 32,001 10,697 44,877 22,349 Interest income (658) (54) (670) (125) Other expense, net 9,619 23,560 14,521 27,890 Income before income tax expense $ 117,008 $ 104,686 $ 262,588 $ 202,753 In the following tables, revenue is disaggregated by customers’ country or region based on the ship to location of the customer for the three and six months ended July 2, 2022 and July 3, 2021, respectively. Three months ended July 2, 2022 (In thousands) SCEM MC AMH Inter-segment Total North America $ 60,766 $ 35,913 $ 73,279 $ (13,457) $ 156,501 Taiwan 33,808 84,132 39,292 — 157,232 China 32,815 43,720 31,802 — 108,337 South Korea 24,789 29,443 30,019 — 84,251 Japan 21,395 46,939 15,501 — 83,835 Europe 15,421 21,319 25,329 — 62,069 Southeast Asia 18,735 12,667 8,862 — 40,264 $ 207,729 $ 274,133 $ 224,084 $ (13,457) $ 692,489 Three months ended July 3, 2021 (In thousands) SCEM MC AMH Inter-segment Total North America $ 54,675 $ 36,148 $ 55,977 $ (9,037) $ 137,763 Taiwan 27,300 53,194 24,865 — 105,359 China 25,219 41,903 25,866 — 92,988 South Korea 25,068 30,951 26,377 — 82,396 Japan 24,659 35,491 12,169 — 72,319 Europe 11,272 15,862 20,636 — 47,770 Southeast Asia 12,173 13,972 6,612 — 32,757 $ 180,366 $ 227,521 $ 172,502 $ (9,037) $ 571,352 Six months ended July 2, 2022 (In thousands) SCEM MC AMH Inter-segment Total North America $ 118,070 $ 71,268 $ 137,620 $ (24,982) $ 301,976 Taiwan 66,312 162,175 73,010 — 301,497 China 59,339 84,241 58,630 — 202,210 South Korea 49,243 63,135 60,028 — 172,406 Japan 44,694 94,598 28,365 — 167,657 Europe 29,110 39,693 47,575 — 116,378 Southeast Asia 37,382 25,660 16,969 — 80,011 $ 404,150 $ 540,770 $ 422,197 $ (24,982) $ 1,342,135 Six months ended July 3, 2021 (In thousands) SCEM MC AMH Inter-segment Total North America $ 103,739 $ 70,740 $ 101,442 $ (18,374) $ 257,547 Taiwan 55,979 98,024 52,671 — 206,674 China 45,881 83,592 46,443 — 175,916 South Korea 50,238 58,962 45,282 — 154,482 Japan 47,139 72,214 24,174 — 143,527 Europe 23,049 26,979 37,130 — 87,158 Southeast Asia 20,882 24,109 13,901 — 58,892 $ 346,907 $ 434,620 $ 321,043 $ (18,374) $ 1,084,196

Subsequent Events

Subsequent Events	6 Months Ended
	Jul. 02, 2022
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTOn July 28, 2022, the Company entered into an interest rate swap agreement. The interest rate swap is a floating-to-fixed interest rate swap contract to hedge the variability in SOFR-based interest payments associated with $1.95 billion of our $2.495 billion Initial Term Loan Facility. The notional amount is scheduled to decrease quarterly and will expire on December 30, 2025. The new interest rate swap was designated as a cash flow hedge based on certain qualitative assessments and we have determined that the hedge is effective and qualifies for hedge accounting.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jul. 02, 2022
Accounting Policies [Abstract]
Nature of Operations	Nature of Operations Entegris, Inc. (“Entegris”, “the Company”, “us”, “we”, or “our”) is a leading supplier of advanced materials and process solutions for the semiconductor and other high-technology industries.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its majority-owned subsidiaries. Intercompany profits, transactions and balances have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, particularly receivables, inventories, property, plant and equipment, right-of-use assets, goodwill, intangibles, accrued expenses, short-term and long-term lease liability, income taxes and related accounts, and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Basis of Presentation	Basis of Presentation The condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States and contain all adjustments considered necessary, and are of a normal recurring nature, to present fairly the financial position as of July 2, 2022 and December 31, 2021, and the results of operations and comprehensive income for the three and six months ended July 2, 2022 and July 3, 2021, the equity statements as of and for the three and six months ended July 2, 2022 and July 3, 2021, and cash flows for the six months ended July 2, 2022 and July 3, 2021. The condensed consolidated financial statements and accompanying notes are presented as permitted by Form 10-Q and do not contain certain information included in the Company’s annual consolidated financial statements and notes. The information included in this Quarterly Report on Form 10-Q should be read in conjunction with Management’s Discussion and Analysis and consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The results of operations for the three and six months ended July 2, 2022 are not necessarily indicative of the results to be expected for the full year.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The carrying value of cash and cash equivalents, restricted cash, accounts receivable, accounts payable, accrued payroll and related benefits, and other accrued liabilities approximates fair value due to the short maturity of those items. The fair value of long-term debt, including current maturities, was $3,141.8 million at July 2, 2022, compared to the carrying amount of long-term debt, including current maturities, of $3,408.8 million at July 2, 2022.
Recent Accounting Pronouncements	Recently Adopted Accounting Pronouncements The Company currently has no material recently adopted accounting pronouncements.

Revenues (Tables)

Revenues (Tables)	6 Months Ended
	Jul. 02, 2022
Revenues [Abstract]
Contract with Customer, Asset and Liability	The following table provides information about current contract liabilities from contracts with customers. The contract liabilities are included in other accrued liabilities balance in the condensed consolidated balance sheet. (In thousands) July 2, 2022 July 3, 2021 Balance at beginning of period $ 23,050 $ 13,852 Revenue recognized that was included in the contract liability balance at the beginning of the period (15,585) (12,306) Increases due to cash received, excluding amounts recognized as revenue during the period 25,770 17,060 Balance at end of period $ 33,235 $ 18,606

Business Combinations and Asset

Business Combinations and Asset Acquisitions (Tables) - Precision Microchemicals	6 Months Ended
	Jul. 02, 2022
Business Acquisition [Line Items]
Schedule of Business Acquisitions, by Acquisition	During the quarter ended April 2, 2022, the Company finalized its fair value determination of the assets acquired and the liabilities assumed. The following table summarizes the final allocation of the purchase price to the fair values assigned to the assets acquired and liabilities assumed at the date of the acquisition: (In thousands): November 30, 2021 As of April 2, 2022 Inventories, net $ 967 $ 967 Other current assets 19 19 Identifiable intangible assets 44,910 44,910 Right-of-use assets 1,912 1,912 Property, plant and equipment 1,002 1,002 Other noncurrent assets 18 18 Accounts payable and accrued liabilities (43) (30) Short-term lease liability (170) (170) Long-term lease liability (1,742) (1,742) Net assets acquired 46,873 46,886 Goodwill 42,819 42,824 Total purchase price, net of cash acquired $ 89,692 $ 89,710
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination	The Company recognized the following finite-lived intangible assets as part of the acquisition of the Precision Microchemicals business: (In thousands) Amount Weighted Developed technology $ 9,600 9.0 Trademarks and trade names 3,400 15.0 Customer relationships 31,800 15.5 Other 110 $ 44,910 14.1

Cash, Cash Equivalents and Re_2

Cash, Cash Equivalents and Restricted Cash (Tables)	6 Months Ended
	Jul. 02, 2022
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]
Restrictions on Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheet that sum to the total of the same amounts shown in the condensed consolidated statement of cash flows. (In thousands) July 2, 2022 December 31, 2021 Cash and cash equivalents $ 252,950 $ 402,565 Restricted cash 2,490,281 — Total cash, cash equivalents and restricted cash $ 2,743,231 $ 402,565

Inventories (Tables)

Inventories (Tables)	6 Months Ended
	Jul. 02, 2022
Inventory Disclosure [Abstract]
Inventories	Inventories consist of the following: (In thousands) July 2, 2022 December 31, 2021 Raw materials $ 258,188 $ 191,986 Work-in-process 49,866 40,257 Finished goods 275,712 242,970 Total inventories, net $ 583,766 $ 475,213

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	6 Months Ended
	Jul. 02, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Goodwill activity for each of the Company’s reportable segments that carry goodwill, Specialty Chemicals and Engineered Materials (“SCEM”), Microcontamination Control (“MC”) and Advanced Materials Handling (“AMH”), for each period was as follows: (In thousands) Specialty Chemicals and Engineered Materials Microcontamination Control Advanced Materials Handling Total December 31, 2021 $ 470,875 $ 248,725 $ 74,102 $ 793,702 Purchase accounting adjustments 5 — — 5 Foreign currency translation (64) (4,103) — (4,167) July 2, 2022 $ 470,816 $ 244,622 $ 74,102 $ 789,540
Schedule of Acquired Finite-Lived Intangible Assets by Major Class	Identifiable intangible assets at July 2, 2022 and December 31, 2021 consist of the following: July 2, 2022 (In thousands) Gross carrying Accumulated Net carrying Developed technology $ 293,829 $ 238,523 $ 55,306 Trademarks and trade names 33,442 21,290 12,152 Customer relationships 481,224 245,190 236,034 Other 20,287 14,908 5,379 $ 828,782 $ 519,911 $ 308,871 December 31, 2021 (In thousands) Gross carrying Accumulated Net carrying Developed technology $ 293,982 $ 232,722 $ 61,260 Trademarks and trade names 33,553 20,340 13,213 Customer relationships 481,674 227,350 254,324 Other 20,505 14,189 6,316 $ 829,714 $ 494,601 $ 335,113
Estimated Future Amortization Expense	Future amortization expense during the remainder of 2022, each of the succeeding four years and thereafter relating to intangible assets currently recorded in the Company’s condensed consolidated balance sheets is estimated to be the following at July 2, 2022: (In thousands) Remaining 2022 2023 2024 2025 2026 Thereafter Total Future amortization expense $ 25,553 50,280 37,490 31,129 28,901 135,518 $ 308,871

Debt (Tables)

Debt (Tables)	6 Months Ended
	Jul. 02, 2022
Debt Disclosure [Abstract]
Schedule of Debt	Long-term debt as of July 2, 2022 and December 31, 2021 consists of the following: (In thousands) July 2, 2022 December 31, 2021 Senior unsecured notes due 2030 $ 895,000 $ — Senior secured notes due 2029 1,600,000 — Senior unsecured notes due 2029 400,000 400,000 Senior unsecured notes due 2028 400,000 400,000 Senior secured term loan facility due 2025 1 145,000 145,000 Revolving facility due 2026 8,000 — 3,448,000 945,000 Unamortized discount and debt issuance costs 39,199 7,973 Total long-term debt $ 3,408,801 $ 937,027
Schedule of Maturities of Long-term Debt	Annual maturities of long-term debt, excluding unamortized discount and issuance costs, due as of July 2, 2022 are as follows: (In thousands) 2022 2023 2024 2025 1 2026 Thereafter Total Contractual debt obligation maturities* $ — — — 145,000 8,000 3,295,000 $ 3,448,000

Earnings Per Common Share (Tabl

Earnings Per Common Share (Tables)	6 Months Ended
	Jul. 02, 2022
Earnings Per Share [Abstract]
Reconcilation of Share Amount Used in Computaion of Basic and Diluted Earnings Per Share (EPS)	The following table presents a reconciliation of the share amounts used in the computation of basic and diluted earnings per common share: Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Basic—weighted common shares outstanding 135,895 135,498 135,783 135,283 Weighted common shares assumed upon exercise of stock options and vesting of restricted common stock 559 1,035 720 1,235 Diluted—weighted common shares and common shares equivalent outstanding 136,454 136,533 136,503 136,518
Shares Excluded Underlying Stock Based Awards from Calculations of Diluted EPS	The Company excluded the following shares underlying stock-based awards from the calculations of diluted EPS because their inclusion would have been anti-dilutive for the three and six months ended July 2, 2022 and July 3, 2021: Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Shares excluded from calculations of diluted EPS 595 167 519 138

Other Expense (Income), net (Ta

Other Expense (Income), net (Tables)	6 Months Ended
	Jul. 02, 2022
Other Income and Expenses [Abstract]
Other expense (income), net	Other expense, net for the three and six months ended July 2, 2022 and July 3, 2021 consists of the following: Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Loss on foreign currency transactions $ 10,046 $ 98 $ 14,623 $ 4,362 Loss on extinguishment of debt and modification — 23,338 — 23,338 Other, net (427) 124 (102) 190 Other expense, net $ 9,619 $ 23,560 $ 14,521 $ 27,890

Segment Reporting (Tables)

Segment Reporting (Tables)	6 Months Ended
	Jul. 02, 2022
Segment Reporting [Abstract]
Summary of Financial Information for Reportable Segments	Summarized financial information for the Company’s reportable segments is shown in the following tables. Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Net sales SCEM $ 207,729 $ 180,366 $ 404,150 $ 346,907 MC 274,133 227,521 540,770 434,620 AMH 224,084 172,502 422,197 321,043 Inter-segment elimination (13,457) (9,037) (24,982) (18,374) Total net sales $ 692,489 $ 571,352 $ 1,342,135 $ 1,084,196 Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Segment profit SCEM $ 45,718 $ 44,945 $ 94,569 $ 79,501 MC 100,107 78,132 198,725 148,698 AMH 46,926 42,093 93,616 74,188 Total segment profit $ 192,751 $ 165,170 $ 386,910 $ 302,387
Reconciliation of Total Segment Profit to Operating Income	The following table reconciles total segment profit to income before income tax expense: Three months ended Six months ended (In thousands) July 2, 2022 July 3, 2021 July 2, 2022 July 3, 2021 Total segment profit $ 192,751 $ 165,170 $ 386,910 $ 302,387 Less: Amortization of intangible assets 12,494 11,902 25,145 23,773 Unallocated general and administrative expenses 22,287 14,379 40,449 25,747 Operating income 157,970 138,889 321,316 252,867 Interest expense 32,001 10,697 44,877 22,349 Interest income (658) (54) (670) (125) Other expense, net 9,619 23,560 14,521 27,890 Income before income tax expense $ 117,008 $ 104,686 $ 262,588 $ 202,753
Schedule of Revenue from External Customers, by Geographical Areas	In the following tables, revenue is disaggregated by customers’ country or region based on the ship to location of the customer for the three and six months ended July 2, 2022 and July 3, 2021, respectively. Three months ended July 2, 2022 (In thousands) SCEM MC AMH Inter-segment Total North America $ 60,766 $ 35,913 $ 73,279 $ (13,457) $ 156,501 Taiwan 33,808 84,132 39,292 — 157,232 China 32,815 43,720 31,802 — 108,337 South Korea 24,789 29,443 30,019 — 84,251 Japan 21,395 46,939 15,501 — 83,835 Europe 15,421 21,319 25,329 — 62,069 Southeast Asia 18,735 12,667 8,862 — 40,264 $ 207,729 $ 274,133 $ 224,084 $ (13,457) $ 692,489 Three months ended July 3, 2021 (In thousands) SCEM MC AMH Inter-segment Total North America $ 54,675 $ 36,148 $ 55,977 $ (9,037) $ 137,763 Taiwan 27,300 53,194 24,865 — 105,359 China 25,219 41,903 25,866 — 92,988 South Korea 25,068 30,951 26,377 — 82,396 Japan 24,659 35,491 12,169 — 72,319 Europe 11,272 15,862 20,636 — 47,770 Southeast Asia 12,173 13,972 6,612 — 32,757 $ 180,366 $ 227,521 $ 172,502 $ (9,037) $ 571,352 Six months ended July 2, 2022 (In thousands) SCEM MC AMH Inter-segment Total North America $ 118,070 $ 71,268 $ 137,620 $ (24,982) $ 301,976 Taiwan 66,312 162,175 73,010 — 301,497 China 59,339 84,241 58,630 — 202,210 South Korea 49,243 63,135 60,028 — 172,406 Japan 44,694 94,598 28,365 — 167,657 Europe 29,110 39,693 47,575 — 116,378 Southeast Asia 37,382 25,660 16,969 — 80,011 $ 404,150 $ 540,770 $ 422,197 $ (24,982) $ 1,342,135 Six months ended July 3, 2021 (In thousands) SCEM MC AMH Inter-segment Total North America $ 103,739 $ 70,740 $ 101,442 $ (18,374) $ 257,547 Taiwan 55,979 98,024 52,671 — 206,674 China 45,881 83,592 46,443 — 175,916 South Korea 50,238 58,962 45,282 — 154,482 Japan 47,139 72,214 24,174 — 143,527 Europe 23,049 26,979 37,130 — 87,158 Southeast Asia 20,882 24,109 13,901 — 58,892 $ 346,907 $ 434,620 $ 321,043 $ (18,374) $ 1,084,196

Summary of Significant Accoun_3

Summary of Significant Accounting Policies Additional details (Details) - USD ($) $ in Thousands	Jul. 02, 2022	Dec. 31, 2021
Accounting Policies [Abstract]
Long-term Debt, Fair Value	$ 3,141,800
Long-term Debt	$ 3,408,801	$ 937,027

Revenues Revenues - Significant

Revenues Revenues - Significant changes in contract liabilities (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 02, 2022	Jul. 03, 2021
Revenues [Abstract]
Balance at beginning of period	$ 23,050	$ 13,852
Revenue recognized that was included in the contract liability balance at the beginning of the period	(15,585)	(12,306)
Increases due to cash received, excluding amounts recognized as revenue during the period	25,770	17,060
Balance at end of period	$ 33,235	$ 18,606

CMC Acquisition (Details)

CMC Acquisition (Details) - USD ($) $ / shares in Units, $ in Thousands		6 Months Ended
	Jul. 06, 2022	Jul. 02, 2022	Jul. 03, 2021
Business Acquisition [Line Items]
Acquisition of businesses, net of cash acquired		$ 0	$ 2,250
CMC Materials | Subsequent Event [Member]
Business Acquisition [Line Items]
Date of acquisition	Jul. 06, 2022
Business Acquisition, Share Price	$ 133
Stock Issued During Period, Shares, Acquisitions	0.4506
Payments to acquire business	$ 5,700,000
Acquisition of businesses, net of cash acquired	$ 3,800,000
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares	12,900,000
Payments for Deposits Applied to Debt Retirements	$ 900,000
Cash Acquired from Acquisition	$ 200,000

Precision Microchemicals Acquis

Precision Microchemicals Acquisition (Details) - USD ($) $ in Thousands		3 Months Ended
	Nov. 30, 2021	Apr. 02, 2022	Jul. 02, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Goodwill			$ 789,540	$ 793,702
Precision Microchemicals
Business Acquisition [Line Items]
Date of acquisition	Nov. 30, 2021
Inventories, net	$ 967	$ 967
Other current assets	19	19
Identifiable intangible assets	44,910	$ 44,910
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		14 years 1 month 6 days
Right-of-use assets	1,912	$ 1,912
Property, plant and equipment	1,002	1,002
Other noncurrent assets	18	18
Accounts payable and accrued liabilities	(43)	(30)
Short-term lease liability	(170)	(170)
Long-term lease liability	(1,742)	(1,742)
Net assets acquired	46,873	46,886
Goodwill	42,819	42,824
Total purchase price, net of cash acquired	$ 89,692	89,710
Precision Microchemicals | Other Intangible Assets
Business Acquisition [Line Items]
Identifiable intangible assets		110
Precision Microchemicals | Developed Technology
Business Acquisition [Line Items]
Identifiable intangible assets		$ 9,600
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		9 years
Precision Microchemicals | Trademarks and Trade names
Business Acquisition [Line Items]
Identifiable intangible assets		$ 3,400
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		15 years
Precision Microchemicals | Customer Relationships
Business Acquisition [Line Items]
Identifiable intangible assets		$ 31,800
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life		15 years 6 months

Cash, Cash Equivalents and Re_3

Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands	Jul. 02, 2022	Dec. 31, 2021	Jul. 03, 2021	Dec. 31, 2020
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]
Cash and cash equivalents	$ 252,950	$ 402,565
Restricted cash	2,490,281	0
Cash and cash equivalents	$ 2,743,231	$ 402,565	$ 401,033	$ 580,893

Inventories (Detail)

Inventories (Detail) - USD ($) $ in Thousands	Jul. 02, 2022	Dec. 31, 2021
Inventory Disclosure [Abstract]
Raw materials	$ 258,188	$ 191,986
Work-in-process	49,866	40,257
Finished goods	275,712	242,970
Total inventories, net	$ 583,766	$ 475,213

Goodwill Rollforward (Details)

Goodwill Rollforward (Details) $ in Thousands	6 Months Ended
	Jul. 02, 2022 USD ($)
Goodwill [Line Items]
Goodwill - Beginning	$ 793,702
Purchase Accounting Adjustments	5
Foreign currency translation	(4,167)
Goodwill - End	789,540
Specialty Chemicals and Electronic Materials SCEM
Goodwill [Line Items]
Goodwill - Beginning	470,875
Purchase Accounting Adjustments	5
Foreign currency translation	(64)
Goodwill - End	470,816
Microcontamination Control MC
Goodwill [Line Items]
Goodwill - Beginning	248,725
Purchase Accounting Adjustments	0
Foreign currency translation	(4,103)
Goodwill - End	244,622
Advanced Materials Handling AMH
Goodwill [Line Items]
Goodwill - Beginning	74,102
Purchase Accounting Adjustments	0
Foreign currency translation	0
Goodwill - End	$ 74,102

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Intangible Assets (Detail) - USD ($) $ in Thousands	Jul. 02, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets
Gross carrying Amount	$ 828,782	$ 829,714
Accumulated amortization	519,911	494,601
Net carrying value	308,871	335,113
Developed Technology
Finite-Lived Intangible Assets
Gross carrying Amount	293,829	293,982
Accumulated amortization	238,523	232,722
Net carrying value	55,306	61,260
Trademarks and Trade names
Finite-Lived Intangible Assets
Gross carrying Amount	33,442	33,553
Accumulated amortization	21,290	20,340
Net carrying value	12,152	13,213
Customer Relationships
Finite-Lived Intangible Assets
Gross carrying Amount	481,224	481,674
Accumulated amortization	245,190	227,350
Net carrying value	236,034	254,324
Other Intangible Assets
Finite-Lived Intangible Assets
Gross carrying Amount	20,287	20,505
Accumulated amortization	14,908	14,189
Net carrying value	$ 5,379	$ 6,316

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets Goodwill and Intangible Assets - Estimated Future Amortization Expense (Detail) - USD ($) $ in Thousands	Jul. 02, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Remaining 2022	$ 25,553
2023	50,280
2024	37,490
2025	31,129
2026	28,901
Thereafter	135,518
Total	$ 308,871	$ 335,113

Debt Summary Table (Details)

Debt Summary Table (Details) - USD ($) $ in Thousands	Jul. 02, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 3,448,000	$ 945,000
Revolving facility due 2026	8,000	0
Unamortized discount and debt issuance costs	39,199	7,973
Long-term Debt	3,408,801	937,027
Senior Unsecured Notes Due 2030
Debt Instrument [Line Items]
Long-term Debt, Gross	895,000	0
Senior Unsecured Notes Due 2029
Debt Instrument [Line Items]
Long-term Debt, Gross	400,000	400,000
Senior unsecured notes due 2028
Debt Instrument [Line Items]
Long-term Debt, Gross	400,000	400,000
Secured Debt
Debt Instrument [Line Items]
Long-term Debt, Gross	145,000	145,000
Senior secured Notes Due 2029
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 1,600,000	$ 0

Debt Maturity (Details)

Debt Maturity (Details) - USD ($) $ in Thousands	Jul. 02, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
2022	$ 0
2023	0
2024	0
20251	145,000
2026	8,000
Thereafter	3,295,000
Long-term Debt, Gross	$ 3,448,000	$ 945,000

CMC Materials Acquisition Finan

CMC Materials Acquisition Financing Debt (Details) - USD ($) $ in Thousands		3 Months Ended	6 Months Ended
	Jul. 06, 2022	Jul. 02, 2022	Jul. 02, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term Debt		$ 3,408,801	$ 3,408,801	$ 937,027
Long-term Debt, Gross		3,448,000	3,448,000	945,000
ticking fee expense		6,900	11,600
Subsequent Event [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 575,000
Line of Credit Facility, Expiration Date	Jul. 06, 2027
Secured Debt
Debt Instrument [Line Items]
Long-term Debt, Gross		$ 145,000	$ 145,000	$ 145,000
Secured Debt | Subsequent Event [Member]
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 2,495,000
Term Loan Rate	3%
Debt Instrument, Description of Variable Rate Basis	2.00
Bridge Loan | Subsequent Event [Member]
Debt Instrument [Line Items]
Bridge Loan	$ 275,000
Term Loan Rate	4.55%
Debt Instrument, Description of Variable Rate Basis	3.55
loan fee percent	0.25%
Revolving Credit Facility | Subsequent Event [Member]
Debt Instrument [Line Items]
Term Loan Rate	1.75%
Debt Instrument, Description of Variable Rate Basis	0.75
umreimbursed letter of credit percentage	35%
Debt Instrument, Covenant Description	5.20:1.00
CMC Materials | Subsequent Event [Member]
Debt Instrument [Line Items]
Date of acquisition	Jul. 06, 2022
CMC Materials | Debt | Subsequent Event [Member]
Debt Instrument [Line Items]
Long-term Debt	$ 3,100,000

2029 and 2030 Debt (Details)

2029 and 2030 Debt (Details) - USD ($) $ in Thousands	6 Months Ended
	Jul. 02, 2022	Jul. 03, 2021	Dec. 31, 2021
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 3,448,000		$ 945,000
Payments for debt issuance costs	$ 10,579	$ 4,691
Debt Instrument, Covenant Compliance	The Company was in compliance with these covenants at July 2, 2022.
Senior secured Notes Due 2029
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 1,600,000		0
Debt Instrument, Interest Rate, Stated Percentage	4.75%
Payments for debt issuance costs	$ 6,300
Debt Instrument, Redemption Price, Percentage	100%
Redemption price, change of control	101%
Senior secured Notes Due 2029 | equity offering
Debt Instrument [Line Items]
Debt Instrument, Interest Rate, Stated Percentage	40%
Senior Unsecured Notes Due 2030
Debt Instrument [Line Items]
Long-term Debt, Gross	$ 895,000		$ 0
Debt Instrument, Interest Rate, Stated Percentage	5.95%
Payments for debt issuance costs	$ 1,700
Debt Instrument, Unamortized Discount	$ 16,700

Earnings Per Common Share - Rec

Earnings Per Common Share - Reconciliation of Share Amount Used in Computation of Basic and Diluted Earnings Per Share (EPS) (Detail) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jul. 02, 2022	Jul. 03, 2021	Jul. 02, 2022	Jul. 03, 2021
Weighted shares outstanding:
Basic-weighted common shares outstanding	135,895	135,498	135,783	135,283
Weighted common shares assumed upon exercise of stock options and vesting of restricted common stock	559	1,035	720	1,235
Diluted-weighted common shares and common shares equivalent outstanding	136,454	136,533	136,503	136,518

Earnings per Common Share - Sha

Earnings per Common Share - Shares Excluded Underlying Stock Based Award from Calucations of Diluted EPS (Detail) - shares shares in Thousands	3 Months Ended		6 Months Ended
	Jul. 02, 2022	Jul. 03, 2021	Jul. 02, 2022	Jul. 03, 2021
Earnings Per Share [Abstract]
Shares excluded from calculations of diluted EPS	595	167	519	138

Other Expense (Income), Net (De

Other Expense (Income), Net (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 02, 2022	Jul. 03, 2021	Jul. 02, 2022	Jul. 03, 2021
Other Income and Expenses [Abstract]
Loss on foreign currency transactions	$ 10,046	$ 98	$ 14,623	$ 4,362
Loss on extinguishment of debt and modification	0	23,338	0	23,338
Other, net	(427)	124	(102)	190
Other expense, net	$ 9,619	$ 23,560	$ 14,521	$ 27,890

Segment Reporting - Summary of

Segment Reporting - Summary of Financial Information for Reportable Segments (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 02, 2022	Jul. 03, 2021	Jul. 02, 2022	Jul. 03, 2021
Segment Reporting Information [Line Items]
Net Sales	$ 692,489	$ 571,352	$ 1,342,135	$ 1,084,196
Total Segment Profit	192,751	165,170	386,910	302,387
Specialty Chemicals and Electronic Materials SCEM
Segment Reporting Information [Line Items]
Net Sales	207,729	180,366	404,150	346,907
Total Segment Profit	45,718	44,945	94,569	79,501
Microcontamination Control MC
Segment Reporting Information [Line Items]
Net Sales	274,133	227,521	540,770	434,620
Total Segment Profit	100,107	78,132	198,725	148,698
Advanced Materials Handling AMH
Segment Reporting Information [Line Items]
Net Sales	224,084	172,502	422,197	321,043
Total Segment Profit	46,926	42,093	93,616	74,188
intersegment elimination
Segment Reporting Information [Line Items]
Net Sales	$ (13,457)	$ (9,037)	$ (24,982)	$ (18,374)

Segment Reporting - Reconciliat

Segment Reporting - Reconciliation of Total Segment Profit to Operating Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 02, 2022	Jul. 03, 2021	Jul. 02, 2022	Jul. 03, 2021
Segment Reporting [Abstract]
Total Segment Profit	$ 192,751	$ 165,170	$ 386,910	$ 302,387
Amortization	12,494	11,902	25,145	23,773
Unallocated general and administrative expenses	22,287	14,379	40,449	25,747
Operating income	157,970	138,889	321,316	252,867
Interest expense	32,001	10,697	44,877	22,349
Interest income	(658)	(54)	(670)	(125)
Other expense, net	9,619	23,560	14,521	27,890
Income before income tax expense	$ 117,008	$ 104,686	$ 262,588	$ 202,753

Segment Reporting - Summary o_2

Segment Reporting - Summary of Financial Information by Reportable Segment and Geography (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 02, 2022	Jul. 03, 2021	Jul. 02, 2022	Jul. 03, 2021
Segment Reporting Information [Line Items]
Net Sales	$ 692,489	$ 571,352	$ 1,342,135	$ 1,084,196
Specialty Chemicals and Electronic Materials SCEM
Segment Reporting Information [Line Items]
Net Sales	207,729	180,366	404,150	346,907
Microcontamination Control MC
Segment Reporting Information [Line Items]
Net Sales	274,133	227,521	540,770	434,620
Advanced Materials Handling AMH
Segment Reporting Information [Line Items]
Net Sales	224,084	172,502	422,197	321,043
intersegment elimination
Segment Reporting Information [Line Items]
Net Sales	(13,457)	(9,037)	(24,982)	(18,374)
North America
Segment Reporting Information [Line Items]
Net Sales	156,501	137,763	301,976	257,547
North America | Specialty Chemicals and Electronic Materials SCEM
Segment Reporting Information [Line Items]
Net Sales	60,766	54,675	118,070	103,739
North America | Microcontamination Control MC
Segment Reporting Information [Line Items]
Net Sales	35,913	36,148	71,268	70,740
North America | Advanced Materials Handling AMH
Segment Reporting Information [Line Items]
Net Sales	73,279	55,977	137,620	101,442
North America | intersegment elimination
Segment Reporting Information [Line Items]
Net Sales	(13,457)	(9,037)	(24,982)	(18,374)
Taiwan
Segment Reporting Information [Line Items]
Net Sales	157,232	105,359	301,497	206,674
Taiwan | Specialty Chemicals and Electronic Materials SCEM
Segment Reporting Information [Line Items]
Net Sales	33,808	27,300	66,312	55,979
Taiwan | Microcontamination Control MC
Segment Reporting Information [Line Items]
Net Sales	84,132	53,194	162,175	98,024
Taiwan | Advanced Materials Handling AMH
Segment Reporting Information [Line Items]
Net Sales	39,292	24,865	73,010	52,671
Taiwan | intersegment elimination
Segment Reporting Information [Line Items]
Net Sales	0	0	0	0
China
Segment Reporting Information [Line Items]
Net Sales	108,337	92,988	202,210	175,916
China | Specialty Chemicals and Electronic Materials SCEM
Segment Reporting Information [Line Items]
Net Sales	32,815	25,219	59,339	45,881
China | Microcontamination Control MC
Segment Reporting Information [Line Items]
Net Sales	43,720	41,903	84,241	83,592
China | Advanced Materials Handling AMH
Segment Reporting Information [Line Items]
Net Sales	31,802	25,866	58,630	46,443
China | intersegment elimination
Segment Reporting Information [Line Items]
Net Sales	0	0	0	0
South Korea
Segment Reporting Information [Line Items]
Net Sales	84,251	82,396	172,406	154,482
South Korea | Specialty Chemicals and Electronic Materials SCEM
Segment Reporting Information [Line Items]
Net Sales	24,789	25,068	49,243	50,238
South Korea | Microcontamination Control MC
Segment Reporting Information [Line Items]
Net Sales	29,443	30,951	63,135	58,962
South Korea | Advanced Materials Handling AMH
Segment Reporting Information [Line Items]
Net Sales	30,019	26,377	60,028	45,282
South Korea | intersegment elimination
Segment Reporting Information [Line Items]
Net Sales	0	0	0	0
Japan
Segment Reporting Information [Line Items]
Net Sales	83,835	72,319	167,657	143,527
Japan | Specialty Chemicals and Electronic Materials SCEM
Segment Reporting Information [Line Items]
Net Sales	21,395	24,659	44,694	47,139
Japan | Microcontamination Control MC
Segment Reporting Information [Line Items]
Net Sales	46,939	35,491	94,598	72,214
Japan | Advanced Materials Handling AMH
Segment Reporting Information [Line Items]
Net Sales	15,501	12,169	28,365	24,174
Japan | intersegment elimination
Segment Reporting Information [Line Items]
Net Sales	0	0	0	0
Europe
Segment Reporting Information [Line Items]
Net Sales	62,069	47,770	116,378	87,158
Europe | Specialty Chemicals and Electronic Materials SCEM
Segment Reporting Information [Line Items]
Net Sales	15,421	11,272	29,110	23,049
Europe | Microcontamination Control MC
Segment Reporting Information [Line Items]
Net Sales	21,319	15,862	39,693	26,979
Europe | Advanced Materials Handling AMH
Segment Reporting Information [Line Items]
Net Sales	25,329	20,636	47,575	37,130
Europe | intersegment elimination
Segment Reporting Information [Line Items]
Net Sales	0	0	0	0
Southeast Asia
Segment Reporting Information [Line Items]
Net Sales	40,264	32,757	80,011	58,892
Southeast Asia | Specialty Chemicals and Electronic Materials SCEM
Segment Reporting Information [Line Items]
Net Sales	18,735	12,173	37,382	20,882
Southeast Asia | Microcontamination Control MC
Segment Reporting Information [Line Items]
Net Sales	12,667	13,972	25,660	24,109
Southeast Asia | Advanced Materials Handling AMH
Segment Reporting Information [Line Items]
Net Sales	8,862	6,612	16,969	13,901
Southeast Asia | intersegment elimination
Segment Reporting Information [Line Items]
Net Sales	$ 0	$ 0	$ 0	$ 0

Subsequent Events (Details)

Subsequent Events (Details) - USD ($) $ in Thousands	Jul. 28, 2022	Jul. 06, 2022	Jul. 02, 2022	Dec. 31, 2021
Subsequent Event [Line Items]
Long-term Debt, Gross			$ 3,448,000	$ 945,000
Subsequent Event [Member]
Subsequent Event [Line Items]
Derivative, Amount of Hedged Item	$ 1,950,000
Secured Debt
Subsequent Event [Line Items]
Long-term Debt, Gross			$ 145,000	$ 145,000
Secured Debt | Subsequent Event [Member]
Subsequent Event [Line Items]
Long-term Debt, Gross		$ 2,495,000